Molecular Partners AG
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MOLN and other ETFs, options, and stocks.About MOLN
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs.
CEOPatrick Amstutz
CEOPatrick Amstutz
Employees174
Employees174
HeadquartersSchlieren, Zurich
HeadquartersSchlieren, Zurich
Founded2004
Founded2004
Employees174
Employees174
MOLN Key Statistics
Market cap164.95M
Market cap164.95M
Price-Earnings ratio-2.21
Price-Earnings ratio-2.21
Dividend yield—
Dividend yield—
Average volume19.91K
Average volume19.91K
High today$4.29
High today$4.29
Low today$4.07
Low today$4.07
Open price$4.10
Open price$4.10
Volume2.21K
Volume2.21K
52 Week high$6.15
52 Week high$6.15
52 Week low$3.36
52 Week low$3.36
Stock Snapshot
The current Molecular Partners AG(MOLN) stock price is $4.29, with a market capitalization of 164.95M. The stock trades at a price-to-earnings (P/E) ratio of -2.21.
During the trading session on 2025-11-15, Molecular Partners AG(MOLN) shares reached a daily high of $4.29 and a low of $4.07. At a current price of $4.29, the stock is +5.3% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 2.21K, compared to an average daily volume of 19.91K.
The stock's 52-week range extends from a low of $3.36 to a high of $6.15.
The stock's 52-week range extends from a low of $3.36 to a high of $6.15.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%